Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-30
Original SEC Filing: Click here

---

Webplus: SVA/20171130/6-K/2_EX-99.1/000.htm SEC Original: tv480520_ex99-1.htm
Sinovac Biotech Announces Update on Nasdaq Matters BEIJING, November 30, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request to extend the stay of suspension in trading of the Company’s common shares pending a hearing on January

---

---

Webplus: SVA/20171130/6-K/1/000.htm SEC Original: tv480520_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085